| Financial Year |
March 31 2023 |
| Monetary Funds |
1,138,693,562.96 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
337,186,391.68 |
| Advances to Suppliers |
48,391,547.87 |
| Other Receivables |
115,600,440.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
158,146,735.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
6,342,786.67 |
| Other Current Assets |
74,425,923.98 |
| Total Current Assets |
1,885,199,081.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
854,270,496.32 |
| Investment Properties |
-- |
| Fixed Assetes |
1,044,813,015.59 |
| Under-construction Projects |
507,090,743.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
333,600,009.62 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
80,162,109.73 |
| Deferred Income Tax Assets |
96,532,783.17 |
| Other Non-Current Assets |
44,008,728.68 |
| Sub-Total of Non-Current Assets |
2,991,171,878.40 |
| Total Assets |
4,876,370,960.00 |
| Short-Term Loans |
415,606,799.54 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
428,916,772.13 |
| Accounts Received In Advance |
15,760,158.07 |
| Employee Compensation Payable |
81,642,205.25 |
| Taxes Payable |
4,013,434.26 |
| Interest Payable |
-- |
| Dividend Payable |
5,773,214.00 |
| Other payables |
621,828,734.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
64,872,278.10 |
| Other Current Liabilities |
27,318,674.30 |
| Sub-Total of Current Liabilities |
1,930,485,339.55 |
| Long-term Loans |
468,863,467.77 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
304,002,863.17 |
| Deferred Income Tax Liabilities |
1,491,791.65 |
| Other Non-Current Liabilities |
46,082,520.00 |
| Sub-Total of Non-Current Liabilities |
930,806,994.37 |
| Total Liabilities |
2,861,292,333.92 |
| Paid-In Capital(Or Share Stock) |
1,012,434,813.00 |
| Capital Surplus |
141,223,983.27 |
| Surplus Reserve |
160,940,937.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
516,063,025.76 |
| Minority Stockholder's Interest |
172,768,956.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,842,309,669.78 |
| Owner's Equity（Stockholder's Equity） |
2,015,078,626.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,876,370,960.00 |
